Articles: 25.17 5 September 2014

A tale of two halves

Mr B is a 70 year-old gentleman who presents to his GP with significant dizziness and is found to be profoundly hypotensive, with a sitting blood pressure of 83/51mmHg.
A tale of two halves

More details...

Current treatment options for acute and chronic gout

Gout is the only curable form of arthritis, yet only a third of patients with chronic gout are receiving appropriate urate-lowering therapy. Our Drug review discusses the available treatment options and their properties, followed by sources of further information.
Current treatment options for acute and chronic …

More details...

Latest reviews from Cochrane

In this section we present an abstract of a review relevant to prescribing in general practice from the latest issue of The Cochrane Database of Systematic Reviews. To view the article in full or for further information, visit www.thecochranelibrary.com
Interferons beta versus glatiramer acetate for relapsing …

More details...

Is oseltamivir effective in reducing symptom duration and complications in children and adults with presumed influenza?

Treatment of children with oseltamivir (Tamiflu) will decrease symptom duration by approximately one day but will not reduce hospitalisations and does not seem to be effective in children with asthma.
Is oseltamivir effective in reducing symptom duration and complications in children and adults

More details...

Malaria prophylaxis: guidance for general practice

Strategies that focus on the prevention of malaria are important in travellers to endemic countries. Here, the author describes the vital role of the GP in educating travellers on malaria risk and prevention and providing prophylactic medications where appropriate.
Malaria prophylaxis guidance for general practice

More details...

Omalizumab: now licensed as adjunct for urticaria

Omalizumab (Xolair), which was originally licensed for IgE-mediated asthma, is now indicated as adjunctive therapy for chronic spontaneous urticaria. In our New products review, Steve Chaplin presents the data relating to its efficacy and adverse events, and Dr Clive Grattan discusses its place in therapy.
Omalizumab …

More details...

Statins: let us identify and treat those at high CV risk first

The use of statins for primary prevention of cardiovascular disease is debated like no other drug. In July NICE added fuel to the debate by recommending that many more people are prescribed statins. Previously the guidelines recommended statins should be offered to people whose estimated …

More details...

Working for Patients: NHS reform and drug budgets

In our series on the history of prescribing policy, Dr Darrin Baines traces how successive governments have attempted to curb drug costs. Here, he describes the controversial reforms introduced following the publication of Working for Patients in 1989.
Working for Patients NHS reform and drug budgets

More details...

Web design and marketing agency Leamington Spa